| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/07/1992 | EP0507187A1 Method for inhibiting pulmonary oxygen toxicity |
| 10/07/1992 | EP0506893A1 Diagnosis and treatment of diseases |
| 10/07/1992 | EP0506890A1 Recombinant thyrotropin receptor |
| 10/07/1992 | EP0506868A1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine. |
| 10/07/1992 | EP0506855A1 Cytokine antibody for the treatment of sepsis |
| 10/07/1992 | EP0506854A1 An improved toxin for construction of immunotoxins |
| 10/07/1992 | EP0506818A1 Method of covalently bonding proteins to hydrophilic surfaces. |
| 10/07/1992 | EP0506815A1 Mucin nucleotides |
| 10/07/1992 | EP0506766A1 Hepatocellular carcinoma oncogene |
| 10/07/1992 | EP0506682A1 Method of determining anti-xanthine oxidase antibody |
| 10/07/1992 | EP0213180B1 Neovascularization inhibitors and methods for their production and use |
| 10/07/1992 | CN1065019A Process for preparing pharmaceutically composition containing polypeptides |
| 10/06/1992 | US5153311 Immunogenic glycoproteins of human cytomegalovirus gCII |
| 10/06/1992 | US5153129 Immunogenic purified protease extracted form malarial parasites which react with protective antibodies orginating form monkeys resistance to human parasites |
| 10/06/1992 | US5153118 Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same |
| 10/04/1992 | CA2064635A1 Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide |
| 10/02/1992 | CA2064413A1 Anti-idiotypic monoclonal antibodies |
| 10/01/1992 | WO1992016837A1 Detection and treatment of ulcerative colitis |
| 10/01/1992 | WO1992016660A1 Methods for detection and treatment of cancer |
| 10/01/1992 | WO1992016656A1 Gene mutated in colorectal cancer of humans |
| 10/01/1992 | WO1992016631A1 SUCROSE PHOSPHATE SYNTHASE (SPS), ITS PROCESS FOR PREPARATION, ITS cDNA, AND UTILIZATION OF cDNA TO MODIFY THE EXPRESSION OF SPS IN THE PLANT CELLS |
| 10/01/1992 | WO1992016628A1 Polypeptides from mycobacterium paratuberculosis |
| 10/01/1992 | WO1992016624A1 Monoclonal antibody against lps core |
| 10/01/1992 | WO1992016621A1 Novel beta integrin subunit |
| 10/01/1992 | WO1992016619A1 Expression of influenza nucleoprotein antigens in baculovirus |
| 10/01/1992 | WO1992016563A1 Monoclonal antibodies recognizing lymphocyte function associated antigen-3 |
| 10/01/1992 | WO1992016561A1 Ovine adipocyte antigens and their use in the immunological control of fat |
| 10/01/1992 | WO1992016558A1 Cell surface receptors homologous to coagulation factors v and viii |
| 10/01/1992 | WO1992016554A1 Protein allergens of the species cynodon dactylon |
| 10/01/1992 | WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 10/01/1992 | WO1992016547A1 Controlling nk-1 receptor-mediated responses and related diagnostics |
| 10/01/1992 | WO1992016543A1 NORWALK VIRUS HUMAN GASTROENTERITIS AGENT AND MOLECULAR CLONING OF CORRESPONDING cDNAs |
| 10/01/1992 | WO1992016292A1 Adsorption matrices |
| 10/01/1992 | WO1992016232A1 Polysaccharide-protein conjugates |
| 10/01/1992 | CA2105993A1 Cell surface receptors homologous to coagulation factors v and viii |
| 10/01/1992 | CA2105876A1 Gene mutated in colorectal cancer of humans |
| 09/30/1992 | WO1992017586A1 Protein having a cytokinin-type activity, recombinant dna coding for this protein, transformed cells and micro-organisms |
| 09/30/1992 | WO1992017188A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | WO1992017187A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | EP0506651A2 Pharmaceutical preparation based on plasma proteins |
| 09/30/1992 | EP0506574A1 Protein having cytokin type activity, recombinant DNA coding for this protein, transformed cells and microorganisms |
| 09/30/1992 | EP0506523A2 Monoclonal antibodies |
| 09/30/1992 | EP0506124A1 Methods and substances for recruiting therapeutic agents to solid issues comprising two single chain VH-VL bifunctional binding molecules |
| 09/30/1992 | EP0505908A1 Chimaeric polypeptides |
| 09/30/1992 | EP0505749A2 Monoclonal antibodies directed to activated endothelial cells and their therapeutic and diagnostic use |
| 09/30/1992 | EP0505566A1 Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
| 09/30/1992 | EP0505488A1 Polypeptide with type iv collagen cell adhesion, spreading and motility activity |
| 09/30/1992 | EP0505387A1 Dna binding proteins including androgen receptor |
| 09/30/1992 | EP0505353A1 Fast printer with a particle trap in the paper channel. |
| 09/30/1992 | CA2107365A1 New non-anticoagulant heparin derivatives |
| 09/30/1992 | CA2107362A1 New non-anticoagulant heparin derivatives |
| 09/29/1992 | US5151504 Method for purification of monoclonal antibodies |
| 09/29/1992 | US5151266 Incubation an immunoreactive component with an anionic detergent and bonding, separation |
| 09/29/1992 | CA2064114A1 Somatostatin receptor |
| 09/29/1992 | CA1308023C Immunoglobulin extraction utilizing properties of colloidal solutions |
| 09/28/1992 | WO1992017192A1 Therapeutic fragments of von willebrand factor |
| 09/28/1992 | CA2107100A1 Therapeutic fragments of von willebrand factor |
| 09/28/1992 | CA2063035A1 Chimaeric antibodies containing the ligand domain of cd4 |
| 09/26/1992 | WO1992016548A1 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 09/26/1992 | CA2106982A1 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 09/23/1992 | EP0505210A2 Assay for measuring the degradation of type I collagen |
| 09/23/1992 | EP0505148A1 Stimulating factor of the neu receptor |
| 09/23/1992 | EP0505034A2 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived therefrom |
| 09/23/1992 | EP0504423A1 Method and kit for immunoassay of propeptide of osteocalcin and proosteocalcin |
| 09/23/1992 | EP0504388A1 Varicella-zoster virus antigen |
| 09/23/1992 | EP0504363A1 PURIFIED IgG ANTIBODIES |
| 09/23/1992 | EP0504350A1 Antibodies directed against cd3 |
| 09/23/1992 | EP0504327A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
| 09/23/1992 | EP0504234A1 ANTIBODIES PREVENTING INTERACTION BETWEEN A FRAGMENT Fc OF AN IMMUNOGLOBULIN AND ITS RECEIVER, AND THERAPEUTIC USE, PARTICULARILY IN TREATING AFFECTIONS LINKED TO THE HIV VIRUS |
| 09/23/1992 | EP0504173A1 Monoclonal antibodies specific for acetyl cholinesterase |
| 09/23/1992 | EP0211899B1 Purification of native colony stimulating factor-1 |
| 09/23/1992 | CN1064684A Insecticidally effective peptides |
| 09/23/1992 | CA2061507A1 Immunogens derived from pathogen-free tick species or cell lines, and tick vaccines derived thereform |
| 09/22/1992 | WO1992016630A1 Dna sequences which code for virulence characteristics of streptococcus suis and parts thereof, polypeptides and antibodies derived therefrom and the use thereof for the diagnosis of and protection against infection by s. suis in mammals, including man |
| 09/22/1992 | US5149786 Free of adrenal and brain derived proteins, useful for treating perkinson's disease and schizophrenia |
| 09/22/1992 | US5149780 60 to 90 amino acid residues in length, ability to prevent receptor mediated cell adhesion such as aggregation of platelets and fibroblasts to a matrix |
| 09/22/1992 | CA1307752C Immunoaffinity purification system |
| 09/19/1992 | WO1992016555A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/19/1992 | CA2736076A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 09/19/1992 | CA2101918A1 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 09/18/1992 | CA2063239A1 Stimulating factor of the neu receptor |
| 09/17/1992 | WO1992015886A1 Detection of early platelet activation and prediagnosis of thrombotic events |
| 09/17/1992 | WO1992015885A1 Methods for selecting antibody reagents; anti-idiotype antibodies; and aids vaccine formulations |
| 09/17/1992 | WO1992015884A1 Novel protein, method and products for detection of oligodendrocytes |
| 09/17/1992 | WO1992015702A1 The biological selection of useful molecules |
| 09/17/1992 | WO1992015699A1 High affinity humanized monoclonal antibodies |
| 09/17/1992 | WO1992015684A1 RECOMBINANT FIV GLYCOPROTEIN 160 AND p24 GAG PROTEIN |
| 09/17/1992 | WO1992015678A1 Pcr generated dicistronic dna molecules for producing antibodies |
| 09/17/1992 | WO1992015613A1 Improved preparation of cat dander allergens for immunotherapeutic purposes and uses therefor |
| 09/17/1992 | WO1992015609A1 Compositions and methods to inhibit the activation of active factor xiii |
| 09/17/1992 | WO1992015603A1 Prad1 cyclin and its cdna |
| 09/17/1992 | WO1992015600A1 Cancer diagnosis and therapy |
| 09/17/1992 | WO1992015330A1 Method for anti-lhrh immunoneutralization for ungelded male domestic animals and peptide therefor |
| 09/17/1992 | WO1992015324A1 Preparation of factor ix |
| 09/17/1992 | WO1992015323A1 Protein-induced morphogenesis |
| 09/17/1992 | WO1992015322A1 Redirection of cellular immunity by receptor chimeras |
| 09/17/1992 | WO1992015320A1 Antigen recognized by patients with antibody associated paraneoplastic sensory neuronopathy, dna encoding same and uses thereof |
| 09/17/1992 | WO1992015195A1 Insecticidally effective peptides |
| 09/17/1992 | WO1992013553A3 Method and agents for promoting wound healing |
| 09/17/1992 | CA2105863A1 Compositions and methods to inhibit the activation of active factor xiii |